Thorsten Wiech Selected Research

Antineutrophil Cytoplasmic Antibodies (ANCA)

3/2024	Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis.
12/2023	The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and Trials.
10/2023	Glucocorticoids target the CXCL9/CXCL10-CXCR3 axis and confer protection against immune-mediated kidney injury.
1/2023	[Role of Complement in Kidney Diseases - New Aspects].
8/2021	Complement catalyzing glomerular diseases.
1/2021	Deep learning-based molecular morphometrics for kidney biopsies.
1/2020	Pathogen-induced tissue-resident memory TH17 (TRM17) cells amplify autoimmune kidney disease.
1/2019	Renal proximal tubular epithelial cells exert immunomodulatory function by driving inflammatory CD4+ T cell responses.
1/2019	Complement Inhibitors in Clinical Trials for Glomerular Diseases.
12/2018	Development and validation of a renal risk score in ANCA-associated glomerulonephritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thorsten Wiech Research Topics

Disease

18	Membranous Glomerulonephritis (Membranous Nephropathy) 11/2023 - 07/2014
17	Proteinuria 02/2023 - 04/2010
16	Glomerulonephritis 12/2023 - 11/2016
12	Kidney Diseases (Kidney Disease) 01/2023 - 01/2017
10	Inflammation (Inflammations) 03/2024 - 09/2015
9	Neoplasms (Cancer) 01/2020 - 03/2005
5	Fibrosis (Cirrhosis) 12/2023 - 09/2011
5	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2023 - 11/2014
5	IGA Glomerulonephritis (IGA Nephropathy) 01/2023 - 01/2019
5	Infections 01/2023 - 09/2015
5	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 01/2016
5	Atypical Hemolytic Uremic Syndrome 01/2023 - 11/2011
4	Vasculitis (Vasculitides) 03/2024 - 01/2018
4	Hypertension (High Blood Pressure) 11/2023 - 08/2014
4	Nephritis 01/2023 - 01/2017
3	COVID-19 01/2023 - 10/2021
3	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2022 - 01/2019
3	Thrombotic Microangiopathies 08/2021 - 01/2019
3	Renal Insufficiency (Renal Failure) 01/2020 - 09/2011
3	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 07/2010
3	Paraganglioma (Paragangliomas) 09/2012 - 01/2012
3	Adenocarcinoma 01/2011 - 08/2007
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 03/2024 - 06/2018
2	Atrophy 12/2023 - 09/2011
2	Albuminuria 01/2023 - 01/2022
2	Disease Progression 12/2021 - 01/2021
2	Necrosis 11/2021 - 01/2020
2	Lupus Nephritis 08/2021 - 01/2019
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2020 - 11/2014
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 12/2018
2	Hypertrophy 01/2019 - 07/2014
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 06/2011
2	Wounds and Injuries (Trauma) 11/2014 - 07/2010
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 09/2012 - 06/2012
2	Pheochromocytoma 09/2012 - 06/2012
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2024
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 02/2024
1	Hypertensive Nephropathy 11/2023
1	Type 2 Diabetes Mellitus (MODY) 10/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Ascites 01/2023
1	Renal Hypertension 01/2023

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2008
15	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2024 - 01/2015
15	Complement System Proteins (Complement)IBA 11/2023 - 09/2015
8	AntigensIBA 11/2023 - 01/2017
7	CreatinineIBA 02/2023 - 11/2010
6	AntibodiesIBA 11/2023 - 01/2017
6	Phospholipase A2 ReceptorsIBA 11/2023 - 01/2017
5	ThrombospondinsIBA 10/2021 - 01/2017
5	DNA (Deoxyribonucleic Acid)IBA 07/2012 - 11/2008
4	Complement Factor H (Factor H)IBA 11/2021 - 01/2018
3	Immunoglobulin G (IgG)IBA 11/2023 - 01/2019
3	Angiotensin IIIBA 11/2023 - 12/2018
3	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 04/2023 - 01/2018
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2023 - 01/2019
3	CytokinesIBA 01/2023 - 01/2020
3	nephrinIBA 01/2023 - 01/2017
3	AutoantibodiesIBA 01/2023 - 10/2021
3	ParaffinIBA 01/2011 - 03/2005
3	Formaldehyde (Formol)FDA Link 01/2011 - 03/2005
2	Peroxidase (Myeloperoxidase)IBA 03/2024 - 01/2018
2	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2024 - 01/2023
2	SaltsIBA 11/2023 - 01/2023
2	Desoxycorticosterone (Deoxycorticosterone)IBA 11/2023 - 01/2023
2	Immunoglobulin A (IgA)IBA 01/2023 - 01/2018
2	AlbuminsIBA 01/2023 - 03/2008
2	Peptides (Polypeptides)IBA 12/2021 - 10/2021
2	AutoantigensIBA 01/2020 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2017
2	Chemokine ReceptorsIBA 12/2018 - 01/2016
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018 - 11/2014
2	Biomarkers (Surrogate Marker)IBA 09/2015 - 11/2014
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 09/2012 - 06/2012
1	EnzymesIBA 03/2024
1	Peptide Hydrolases (Proteases)FDA Link 03/2024
1	ibrutinibIBA 02/2024
1	NPHS2 proteinIBA 02/2024
1	Anaphylatoxin C5a ReceptorIBA 11/2023
1	Complement C3a (Complement 3a)IBA 11/2023
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 11/2023
1	Complementary DNA (cDNA)IBA 11/2023
1	AnaphylatoxinsIBA 11/2023
1	Complement C5a (Complement 5a)IBA 11/2023
1	SteroidsIBA 10/2023
1	GlucocorticoidsIBA 10/2023
1	RNA (Ribonucleic Acid)IBA 10/2023
1	Methylprednisolone FDA LinkGeneric 01/2023
1	Tamoxifen FDA LinkGeneric 01/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	Acetates (Acetic Acid Esters)FDA Link 01/2023
1	Prednisolone (Predate)FDA LinkGeneric 01/2023
1	VaccinesIBA 01/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023
1	Complement C5 (Complement 5)IBA 01/2023
1	AcetylgalactosamineIBA 01/2023

Therapy/Procedure

8	Therapeutics 01/2023 - 03/2010
3	Kidney Transplantation 01/2023 - 01/2019
1	Plasmapheresis 01/2023